Gene · 54578
Papers1,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of vulnerable antimalarial targets using conditional loss of function mutants. | Mol Biochem Parasitol | 2026 | 42570799 | PubTator, text mining | PubMed |
| Differential role for hepatic glucuronidation and sulfonation in controlling the 24S-hydroxycholesterol ability to activate LXR. | Sci Rep | 2026 | 42443275 | PubTator, text mining | PubMed |
| Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in Zimbabwe. | S Afr Med J | 2026 | 42246857 | PubTator, text mining | PubMed |
| Overlooked aspects of scaling enzyme activity through abundance across tissues and individuals: Insights from kcat measurements in matched liver and intestinal samples. | Drug Metab Dispos | 2026 | 41855594 | PubTator, text mining | PubMed |
| Aster koraiensis Nakai: Insights into Its Phytoconstituents and Pharmacological Properties. | Pharmaceutics | 2026 | 41754924 | PubTator, text mining | PubMed |
| Pterostilbene in the Management and Treatment of Multiple Myeloma. | Curr Issues Mol Biol | 2026 | 41751478 | PubTator, text mining | PubMed |
| Evaluation of Cat Exposure to Bisphenol A (BPA) Using Hair Sample Analysis. | Animals (Basel) | 2026 | 41751028 | PubTator, text mining | PubMed |
| The Effect of Uridine Diphosphate-Glucuronosyltransferase Inhibition on the Pharmacokinetics of Ecopipam and Its Metabolites. | Clin Transl Sci | 2026 | 41693270 | PubTator, text mining | PubMed |
| The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications. | Clin Transl Sci | 2026 | 41635062 | PubTator, text mining | PubMed |
| Comparative Proteomics of Hepatocytes And Hepatic Cell Lines Using Swath-MS Reveals Significant Variations In Proteins Involved In Energy, Lipid, And Xenobiotic Metabolism. | Curr Drug Metab | 2026 | 41588973 | PubTator, text mining | PubMed |
| High Risk of Drug-Drug Interactions Caused by Pexidartinib via UDP-Glucuronosyltransferases Inhibition. | Chem Res Toxicol | 2026 | 41575265 | PubTator, text mining | PubMed |
| UGT1A6 variants and deferiprone-induced ADRs: a complication-specific analysis in Iranian thalassemia patients. | Pharmacogenomics | 2025 | 41622710 | PubTator, text mining | PubMed |
| Antimicrobial potentials and challenges of paracetamol: A comprehensive reassessment based on database reports. | Pharm Sci Adv | 2025 | 41550649 | PubTator, text mining | PubMed |
| Radiotherapy-Related Autophagy Genes Predict Prognosis and Reveal Immunoscape Features and Immunotherapeutic Agents in Colorectal Cancer Patients. | J Environ Pathol Toxicol Oncol | 2025 | 41213063 | PubTator, text mining | PubMed |
| Pharmacogenomics of antibiotic-induced hypersensitivity reactions: current evidence and implications in clinical practice. | Front Pharmacol | 2025 | 41104340 | PubTator, text mining | PubMed |
| Multi-omic insight into the causal networks of arsenic-related genes in the pathogenesis of type 2 diabetes mellitus. | Ecotoxicol Environ Saf | 2025 | 41072314 | PubTator, text mining | PubMed |
| Exploring the Cellular and Molecular Landscape of Idiopathic Pulmonary Fibrosis: Integrative Multi-Omics and Single-Cell Analysis. | Biomedicines | 2025 | 41007698 | PubTator, text mining | PubMed |
| Extracting Clinical Guideline Information Using Two Large Language Models: Evaluation Study. | J Med Internet Res | 2025 | 40911841 | PubTator, text mining | PubMed |
| Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer. | NPJ Precis Oncol | 2025 | 40825842 | PubTator, text mining | PubMed |
| Expression of the aryl hydrocarbon receptor (AhR) in facial melasma skin compared to healthy perilesional skin. | An Bras Dermatol | 2025 | 40812224 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54578/papers